FDA Adverse Event Injury Summary report: N

GORE® CARDIOFORM ASD OCCLUDER

MDR report key: 9535807 · Received December 31, 2019

Report

Report Number
2017233-2019-01283
Event Type
Injury
Date Received
December 31, 2019
Date of Event
June 26, 2019
Report Date
December 20, 2019
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MLV
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PMA#: P050006.

Description of Event or Problem · 1

THE FOLLOWING INFORMATION WAS OBTAINED THROUGH THE CLINICAL STUDY ASD 15-04: IT WAS REPORTED THE PHYSICIAN IMPLANTED A GORE® CARDIOFORM ASD OCCLUDER ON (B)(6) 2019. ON (B)(6) 2019 THE PATIENT REPORTED PALPITATIONS ALMOST NIGHTLY WHEN LYING DOWN THEY WERE NOTED TO SELF-RESOLVE AFTER A TIME. THE ARRHYTHMIA WAS DOCUMENTED WITH ECG. THE PATIENT WAS GIVEN METOPROLOL 25MG FOR HEADACHES AND PALPITATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1329947 GORE® CARDIOFORM ASD OCCLUDER TRANSCATHETER, SEPTAL OCCLUDER MLV W.L. GORE & ASSOCIATES 16202262

Patients

Seq Age Sex Outcome Treatment
1 21 YR Other